Selenium in the Treatment of Complicated Lymphatic Malformations
Status:
Terminated
Trial end date:
2012-11-01
Target enrollment:
Participant gender:
Summary
The investigators propose a pilot trial to obtain preliminary information regarding the
safety and response rate of patients with symptomatic lymphatic malformations treated with
oral Selenium. Information obtained in this pilot trial will be used to plan future phase 2
clinical trials.
Hypotheses:
- Selenium will be safe and efficacious in the treatment of adolescents and young adults
with symptomatic lymphatic malformations
- Disease response will correlate with serum levels of selenium and blood levels of
antioxidants essential to selenium metabolism.